New thesis highlights challenges for doctors while certifying sickness for patients with mental disorders
Nearly nine out of ten doctors in primary care think a decision on sickness absence is improved if they are in touch with the patient's employer -; but only four out of ten are. A University of Gothenburg thesis highlights…
Read MoreBlood clots: Two ‘deadly’ risk factors that could lead to an embolism
BBC journalist’s husband emotionally recalls wife’s blood clots We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding….
Read MoreRethinking how drugs are administered: A breakthrough in microneedle patches
The painful feeling of receiving an injection through a hypodermic needle or with the unpleasant sensation of swallowing a large pill is a globally familiar sensation. But what if a revolutionary and gentler way of administering drugs was in the…
Read MoreCOVID-19 Vaccinations in People With HIV Match Community Rates
Around the world, people with HIV show variations in COVID-19 vaccination rates similar to those seen in the general population, raising concerns because of their increased risk for morbidity and mortality from COVID-19 infection. “To our knowledge, this analysis presents…
Read MoreMiracle baby born the size of an iPhone spends first Christmas at home
Parents of a baby born 14 weeks premature say their son has had a ‘rollercoaster’ of a year. But thankfully, he was able to spend his first Christmas at home in Glasgow. Little Myles weighed just 1lb 8oz, the size…
Read MoreWear and tear in vulnerable brain areas lead to lesions linked to cognitive decline
As our brains age, small lesions begin to pop up in the bundles of white matter that carry messages between our neurons. The lesions can damage this white matter and lead to cognitive deficits. Now, researchers at Stevens Institute of…
Read MoreAd5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows
One dose of Ad5-nCoV (Convidecia), a COVID-19 vaccine developed in China, is 57.5% effective against symptomatic COVID-19 and 91.7% effective against severe COVID-19 disease beginning 28 days postvaccination, according to a phase 3 randomized controlled trial published in The Lancet….
Read MoreProgram Assists Substance-Exposed Infants, Their Caregivers
Phoenix (AP) — Pregnant with her second child, Clarissa Collins was at her methadone clinic when a woman walked in with a box of doughnuts and a baby doll. The woman, Tara Sundem, was partway through a five-year effort to…
Read MoreS.Korea authorises emergency use of Pfizer's oral coronavirus treatment
FILE PHOTO: Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS SEOUL (Reuters) -South Korea authorised for emergency use Pfizer’s antiviral…
Read MoreOmicron symptoms: The sign on your skin which could be signalling the new variant
Omicron: 'Rash' symptom in children discussed by Dr Nighat We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our…
Read More